Heterogeneity in fibroblast proliferation and survival in idiopathic pulmonary fibrosis.
about
Fibrocytes Regulate Wilms Tumor 1-Positive Cell Accumulation in Severe Fibrotic Lung Disease.Oncostatin M-Preconditioned Mesenchymal Stem Cells Alleviate Bleomycin-Induced Pulmonary Fibrosis Through Paracrine Effects of the Hepatocyte Growth FactorPromising new treatment targets in patients with fibrosing lung disorders.MicroRNA-21 in Skin Fibrosis: Potential for Diagnosis and Treatment.Expression dynamics of caveolin-1 in fibroblasts of newborn rats with chronic lung disease and its impact on lung fibroblast proliferation.Enhanced neointimal fibroblast, myofibroblast content and altered extracellular matrix composition: Implications in the progression of human peripheral artery restenosisTherapeutic potential of adipose stem cell-derived conditioned medium against pulmonary hypertension and lung fibrosis.Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.BDNF/TrkB axis activation promotes epithelial-mesenchymal transition in idiopathic pulmonary fibrosis.Glabridin inhibits the activation of myofibroblasts in human fibrotic buccal mucosal fibroblasts through TGF-β/smad signaling.Inhibitory effect of GMI, an immunomodulatory protein from Ganoderma microsporum, on myofibroblast activity and proinflammatory cytokines in human fibrotic buccal mucosal fibroblasts.CCL21 and IP-10 as blood biomarkers for pulmonary involvement in systemic lupus erythematosus patients.Heterogeneity of Fibroblasts and Myofibroblasts in Pulmonary Fibrosis.Wilms' tumor 1 drives fibroproliferation and myofibroblast transformation in severe fibrotic lung diseaseContribution of STAT3 to Inflammatory and Fibrotic Diseases and Prospects for its Targeting for Treatment
P2860
Q28390280-E8A65D6C-F2DF-420A-9239-C1617AA2BC03Q33722290-B47A0E15-7FD1-49A9-A794-7543FF6B4601Q38269057-D0693F9C-8CA0-464B-B3E3-217AA6718A04Q38654746-E2702866-917A-405E-8D58-3D9E9823E4B4Q38738138-68F7EBC4-8BBD-44BF-9C59-4A5BE43C3886Q38843287-999867A9-33D8-43E2-8FAF-5607334F5906Q41635365-432E7B28-F65D-4AEB-B90F-0AC8EDA77863Q42005326-DC73A3C1-D97A-4157-99A0-A6BE8A661690Q42363010-1B3E8626-27A0-4EE9-9C93-6D42916A49DBQ47422409-A69CC0FA-DA32-484D-9F31-ED49F185BF7AQ47688363-98B07040-0D90-4F07-B475-126F3E498B3EQ51457612-04897BC6-E80E-46AF-B5A3-C2A360CDB817Q55143948-5B83A419-FDE1-4F92-9D70-A4FA80512C30Q56981752-525951D8-4E5B-4968-B93A-4545892108F2Q58799997-4F4F5756-3BBC-4ECE-8696-A3DB93D72988
P2860
Heterogeneity in fibroblast proliferation and survival in idiopathic pulmonary fibrosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Heterogeneity in fibroblast proliferation and survival in idiopathic pulmonary fibrosis.
@en
type
label
Heterogeneity in fibroblast proliferation and survival in idiopathic pulmonary fibrosis.
@en
prefLabel
Heterogeneity in fibroblast proliferation and survival in idiopathic pulmonary fibrosis.
@en
P2860
P356
P1476
Heterogeneity in fibroblast proliferation and survival in idiopathic pulmonary fibrosis.
@en
P2093
Cory Hogaboam
David M Habiel
P2860
P356
10.3389/FPHAR.2014.00002
P577
2014-01-23T00:00:00Z